Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Leon Precision Capital is a venture capital firm located in San Francisco and Palo Alto, California. Founded to identify and support innovative early-stage companies, the firm focuses on high-impact solutions in the biotech and healthcare sectors. The organization aims to transform patient outcomes through strategic investments and mentorship.
Currently, Leon Precision Capital operates with a team led by Angela Jimenez, MD, who serves as the Physician Leader for Life Sciences Investments. The firm emphasizes leveraging deep industry expertise and data-driven insights to support innovative solutions that can lead to life-changing therapies and technologies. Although specific fund sizes and assets under management (AUM) are not disclosed, the firm is actively involved in the early-stage investment landscape.
Leon Precision Capital has established a presence in the Bay Area, which allows it to tap into a rich network of healthcare and biotech professionals. The firm has been involved in mentoring startups through programs such as Nucleate and Stanford Engineering, focusing on healthcare innovations and personalized drug therapies.
Leon Precision Capital invests primarily in early-stage companies within the biotech and healthcare sectors, specifically targeting pre-seed, seed, and Series A stages. The firm emphasizes investments that leverage clinical evidence and innovative solutions capable of transforming patient outcomes. Their investment strategy is rooted in a deep understanding of the healthcare landscape, allowing them to identify companies that can deliver life-changing therapies and technologies.
The firm’s geographic focus is primarily on North America, particularly the United States. Leon Precision Capital seeks to partner with founders who demonstrate a strong commitment to their vision and possess the capability to navigate the complexities of the healthcare market. They value data-driven insights and clinical validation in the companies they consider for investment.
Leon Precision Capital also engages in co-investment opportunities and provides strategic guidance to portfolio companies, enhancing their chances of success in a competitive market. The firm’s approach includes a strong emphasis on mentorship and support, ensuring that founders have access to the resources they need to thrive.
Leon Precision Capital has been actively involved in mentoring startups through various programs, although specific portfolio companies have not been publicly disclosed. The firm has participated in initiatives such as:
While no specific investments have been verified, the firm’s involvement in these programs indicates a strong focus on supporting innovative healthcare solutions and fostering the next generation of biotech startups.
Angela Jimenez, MD - Physician Leader - Life Sciences Investments. Dr. Jimenez brings a wealth of experience in the healthcare sector, with a background that includes roles in government, hospitals, funds, startups, and nonprofits. She holds an MD and MPS, and has been recognized for her contributions to the field, including participation in panels focused on clinical trials and digital health technologies.
To pitch to Leon Precision Capital, founders should use the interest form available on their website. It is essential to include a comprehensive overview of the startup, highlighting the innovation, market potential, and clinical evidence supporting the proposed solution. The firm values detailed presentations that clearly outline the startup's vision and strategy.
While specific response time expectations are not disclosed, founders should anticipate a thorough review process. Warm introductions may enhance the chances of receiving a timely response, so leveraging connections within the Bay Area network could be beneficial.
Leon Precision Capital runs the Nucleate Program, which focuses on mentoring startups in the healthcare sector. This program aims to support innovative solutions and personalized drug therapies, providing valuable guidance and resources to emerging companies.
In January 2025, Leon Precision Capital announced its involvement in mentoring startups through the Nucleate Program, focusing on healthcare innovations and personalized drug therapies. Additionally, Dr. Angela Jimenez participated in a Women In Bio event in March 2025, discussing the intersection of AI and digital health technologies.
What are Leon Precision Capital's investment criteria?
Leon Precision Capital focuses on early-stage biotech and healthcare companies that demonstrate the potential to transform patient outcomes. They look for strong clinical evidence, innovative solutions, and a credible pathway through regulatory processes.
How can I pitch my startup to Leon Precision Capital?
Founders can submit their startups for consideration through the interest form available on their website. The firm encourages detailed presentations that highlight the innovation and potential impact of the proposed solutions.
What makes Leon Precision Capital different from other investors?
Leon Precision Capital differentiates itself through its deep industry expertise and commitment to mentorship. The firm actively engages in programs like Nucleate and Stanford Engineering, providing valuable insights and connections to portfolio companies.
What is the geographic scope of Leon Precision Capital's investments?
The firm primarily focuses on investments within North America, specifically the United States. Their presence in the Bay Area allows them to leverage local networks and resources effectively.
What is the typical check size for investments?
While specific check sizes have not been disclosed, Leon Precision Capital targets early-stage investments, which typically range from pre-seed to Series A funding rounds.
What kind of support can portfolio companies expect?
Leon Precision Capital provides strategic guidance, access to Bay Area networks, and founder empathy to help portfolio companies navigate the complexities of the healthcare landscape. This support includes mentorship and resources to enhance their chances of success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.